About us
SynapCon was founded in 2006 to supply technical and organizational services for clinical drug development.
Following the founding idea of SynapCon, we focused on the development and marketing of outstanding IT solutions.
This focus also allows us to work for clinical service providers.
Our products are developed in collaboration with excellent development teams and specialists.
In close cooperation with our customers and many other market players, we are working to realize our common vision of providing optimal and affordable medical care worldwide.
Only the harmonious interaction of professional expertise combined with outstanding skills in technical development creates the prerequisites for creating complex architectures.
Our vision
A digital health approach that makes a difference for all stakeholders (including patients, doctors & payers) by IT powered management of drug and medical device development. It is our vision to innovate the clinical trials world through disrupting outdated processes and organizational structures.
Our innovative solutions optimize the interfaces between patient data, clinics and the industry that develops drugs and medical devices.
This includes the implementation of our digital solutions and coordinated consulting to optimize your processes.
You benefit from our market knowledge of the entire medical value chain.
Our goal is to provide our customers with profitable advantages from the current challenges of the market.
Our commitment and technical expertise helps shorten development cycles to ensure faster patient care and reduce development costs to make innovative medicines affordable.
Target Market
Diagnostics & medical device companies
Pharmaceutical companies
Biotechnology companies
Target Market
Diagnostics & medical device companies
Pharmaceutical companies
Biotechnology companies
Business Model
A digital health approach that makes a difference for all stakeholders (including patients, doctors & payers) by IT powered management of drug and medical device development. It is our vision to innovate the clinical trials world through disrupting outdated processes and organizational structures.
Change the game – use software solutions to perform clinical research projects more efficiently then ever before.
Our business model combines innovative IT product solutions and related consultancy support implemented by a lean organization built of IT-affine, curious, entrepreneurial, self responsible people & supported by our competitive FIDAS strategy.
Competitive Advantage
Our unique approach of Rethinking Clinical Research Operations
Focused│Integrated│Digitised│Automatised│Specialised (FIDAS)
Our proprietary IT systems: EasyClin© & CLiNSTORM© (artificial intelligence based solution in development)
Use our EU-GDPR compliant videoconferencing system to reduce the number of patient visits in your clinical research projects
Competitive Advantage
Our unique approach of Rethinking Clinical Research Operations
Focused│Integrated│Digitised
Automatised│Specialised (FIDAS)
Our proprietary IT systems: EasyClin© & CLiNSTORM© (artificial intelligence based solution in development )
Our enterprises
SynapCon Group develops new ways to set standards in clinical research through digital transformation.
We provide consultancy practice within the health market, investors and business arena
Success is at the heart of every project. We are committed to being a pillar of your success at all levels. Our unique approach is to rethink the Clinical Research approach by combining the latest IT solutions with clinical operations services to improve the value chains. This hybrid model ultimately forms the SynapCon Group’s innovative approach called CROIT (Clinical Research Operations Information Technology).
We help companies evolve within the complex healthcare environment. Our team of professionals supports companies in their development from a clinical, financial and entrepreneurial point of view.
Cutting-edge solutions through new thinking
We are optimizing interfaces between patient data, clinics and industry developing drugs and medical devices. Our mission is to implement a structure, based on a novel organizational partner structure and digital technologies. Our goals are: to positively influence the medical value chain in the health market to generate benefits for the community, this means, shortening development cycles to ensure faster patient care and reducing development costs to make innovative medicine affordable.
Our unique approach of Rethinking Clinical Research Operations is to build IT systems to further increase innovation within the clinical research market.
Efficently manage clinical research studies
Our Software solutions reduce the number of platforms in clinical research and, consequently, the costs of validating interfaces, maintenance, support and training. Our software reduces the time to market and extends the patent-protected marketing of your products. We always keep our eyes on the patients, providing people with a faster access to life-saving medical products is our driving force and shapes our actions.
EasyClin© is a newly designed platform and cost-effective software solution for your clinical research projects. This system will in future be the core of your study communication.
The system is designed to cover all requirements from the strictest regulations in Europe (EU-GDPR), US (21CFR Part 11) and ICH-GCP E6 R2.
The EasyClin(c) feasibility module is ready for release in May 2019, the eTMF module in June.
This project has received funding from the European Union’s Horizon 2020 research and Innovation programme under grant Agreement No 691546
EasyClin© provides an integrated and regulatory compliant platform to effectively and efficiently manage clinical research studies.
Together with our partner QBITCRC Solutions Ltd., a subsidiary of AIFINITY Holding Ltd., we are developing the CLiNSTORM© system, developed by our CEO, using state-of-the-art technologies.
In the future, it will be possible to map clinical development processes as autonomously as possible. The cost savings (without considering the longer patent life) will be up to 70%.
The first modules are planned to be available until 3rd quarter 2019.
The CLiNSTORM© solution looks to meet the need of this target group of delivering a very scalable low cost solution.
We provide consultancy practice within the health market, finance and business arena
Success is at the heart of every project. We are committed to being a pillar of your success at all levels. Our unique approach is supporting our customers rethinking the Clinical Research approach by combining the latest IT solutions with clinical operations services to improve the value chains. This hybrid model ultimately forms the SynapCon Group’s innovative approach called CROIT (Clinical Research Operations Information Technology).
We help companies evolve within the complex healthcare environment. Our team of professionals supports companies in their development from a clinical, financial and entrepreneurial point of view.
Driving innovation through proprietary IT systems
We operate as a “Clinical Research Organization” (CRO) which optimizes interfaces between patient data, clinics and industry developing drugs and medical devices. Our mission is to implement a CRO 4.0, based on a novel organizational structure and digital technologies. Our goals are: taking profitable advantages out of current challenges in the CRO market to generate values, shortening development cycles to ensure faster patient care and reducing development costs to make innovative medicine affordable.
Our unique approach of Rethinking Clinical Research Operations (CROs) is to build IT systems to further increase innovation within the clinical research market.
Efficently manage clinical research studies
Our Software solutions reduce the number of platforms in clinical research and, consequently, the costs of validating interfaces, maintenance, support and training. Our software reduces the time to market and extends the patent-protected marketing of your products. We always keep our eyes on the patients, providing people with a faster access to life-saving medical products is a driving force and shapes our actions.
EasyClin© is a newly designed platform and cost-effective software solution for your clinical research projects. Following the successful release of our application to conduct clinical feasibility studies, we are pleased to welcome you to our Management System today. This system (and today it will gain access to the important area of document management) will in future be the core of your study communication. The type of access and availability are based on the social networks in the future. The authorization management fulfills the highest requirements also from the side of the regulators. Our three-way staggered hybrid model grows to meet your needs. Take care of the essentials, leave the rest to technology.
EasyClin provides an integrated and regulatory compliant platform to effectively and efficiently manage clinical research studies supported by the European Commission.
CLiNSTORM triples clinical research cost effciency and speed
CLiNSTORM©’s core business is delivering a smart and low cost cloud-client based solution for organizations to manage their clinical trials of medical devices, diagnostics and biopharmaceutics.
CLiNSTORM© is the brand of the organization as well as the name for the comprehensive solution offered. As the brand name suggests CLiNSTORM© will take the market by storm. This enabled by its revolutionary business model by being the first business within the clinical research industry that lets the customer pay by what they use; pay pro data point.
The CLiNSTORM© solution looks to meet the need of this target group of delivering a very scalable low cost solution.
Clinical executive team
Synapcon is managed by a highly experienced team, with offices throughout Europe and a global network of clients.
Sven Engel
CEO, CIO & Founder of SynapCon Ltd., co-founder and COO of SWIL Systems GmbH
Biotechnologist, Clinical Researcher, 20 years of entrepreneurial experience, deep insight in the whole value chain of bio-pharmaceutical and medical product development, organisation and software developer, visionary and strategic thinking with the power to translate knowledge and information into products.
Holger Fuhrmann
HR Manager SynapCon Group
Head Talent Acquisition & Development, MBA (International Marketing) & Business Coach (DBVC), 17 years experience in the search, selection and development of specialist and executive staff in the life science industry, Founder and CEO of PHARECON (executive search company with life science focus in Europe).
Seko Williams
COO of SynapCon Ltd., CEO & Founder of SWIL Systems GmbH
Entrepreneur, Economist, Physical Therapist, +10 years entrepreneurial experience, +9 years of experience in health care and physical training optimisation. Active project management & lean software development, for videoconferencing and calendar tools in digital healthcare. Developer of the first and only independently audited B2C videoconferencing platform for doctors & physician in Germany, in accordance with GDPR standards and federal medical association videoconferencing conditions.
Joachim Löw
CFO and co-founder of SynapCon Ltd., founder of Schulz&Löw Consulting
Business economist, controller and IT specialist with extensive experience in the implementation and development of business management software. Joachim works as an interim financial manager for a listed US company.
Our News
We are active in a number of medical research activities. As a rule, we supply the product idea and then find the right partners for its implementation. We are often approached with ideas, which we then elaborate and present to our development partners. After the decision for further development has been made, we start the implementation and investor search.
Together with Evaluation Software Development, we develop EasyClin(c), the most effective way to manage clinical trials. EasyClin(c) feasibility will go online shortly. EasyTMF(c) will follow shortly. Our CEO Sven Engel also accompanies the role of COO at SWIL Sytems UG. Their GDPR-certified product Zumedu sets standards in patient-doctor communication and will be integrated into EasyClin(c) as an additional module to reduce the number of patient visits in clinical trials.
Together with Aifinity Holdings Ltd, we are developing ClinStorm(c), a system based on technical intelligence to automate clinical research processes. This development takes place in close cooperation with the innowise Group.
Sorry, no posts matched your criteria.